|Test||Age <21||Age 21-24||Age 25-29||Age 30-65||Age >65|
|PAP||Not recommended for screening||Screen every 3 years||Screen every 3 years||Screen every 3 years||Screening should be discontinued if patient has had adequate negative prior screening results and no history of CIN2+. See ACOG Practice Bulletin No. 168 for management of patient with history of CIN2+.|
|HPV||Not recommended for screening||Reflex to high-risk HPV when Pap is ASCUS is acceptable||Reflex to high-risk HPV is preferred when Pap is ASCUS||Screen every 5 years if both HPV and Pap are negative|
|HPV genotyping||Not recommended for screening||Not recommended for screening||Not recommended for screening||If Pap is normal and HPV positive, reflex to HPV genotyping||If Pap is normal and HPV positive, reflex to HPV genotyping|
|Ct/Ng||If 24 years of age or younger and sexually active||If 24 years of age or younger and sexually active||If 25 years of age or older and have risk factors||If 25 years of age or older and have risk factors||Not recommended for screening|
Screening guidelines can be complex – Labcorp’s age-based test protocol for cervical cancer and STD screening can help individualize patient care.
Our age-based protocol follows the current ACOG guidelines. As ACOG guidelines evolve and change, if the test or age protocol is affected, Labcorp will update its test protocol in accordance with the guidelines.